These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17910915)

  • 41. Cell biology. Integrin crystal structure solved.
    Couzin J
    Science; 2001 Sep; 293(5536):1743-6. PubMed ID: 11546844
    [No Abstract]   [Full Text] [Related]  

  • 42. Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists.
    Li FN; Kim NJ; Paek SM; Kwon DY; Min KH; Jeong YS; Kim SY; Park YH; Kim HD; Park HG; Suh YG
    Bioorg Med Chem; 2009 May; 17(10):3557-67. PubMed ID: 19398205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.
    Hattori K; Orita M; Toda S; Imanishi M; Itou S; Nakajima Y; Tanabe D; Washizuka K; Araki T; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4679-83. PubMed ID: 19608416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
    Meissner RS; Perkins JJ; Duong LT; Hartman GD; Hoffman WF; Huff JR; Ihle NC; Leu CT; Nagy RM; Naylor-Olsen A; Rodan GA; Rodan SB; Whitman DB; Wesolowski GA; Duggan ME
    Bioorg Med Chem Lett; 2002 Jan; 12(1):25-9. PubMed ID: 11738566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis.
    Ryckmans T; Edwards MP; Horne VA; Correia AM; Owen DR; Thompson LR; Tran I; Tutt MF; Young T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4406-9. PubMed ID: 19500981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.
    Aki C; Chao J; Ferreira JA; Dwyer MP; Yu Y; Chao J; Merritt RJ; Lai G; Wu M; Hipkin RW; Fan X; Gonsiorek W; Fosseta J; Rindgen D; Fine J; Lundell D; Taveras AG; Biju P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4446-9. PubMed ID: 19525110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.
    Raval S; Raval P; Bandyopadhyay D; Soni K; Yevale D; Jogiya D; Modi H; Joharapurkar A; Gandhi N; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3919-24. PubMed ID: 18585912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis.
    Rosen MD; Hack MD; Allison BD; Phuong VK; Woods CR; Morton MF; Prendergast CE; Barrett TD; Schubert C; Li L; Wu X; Wu J; Freedman JM; Shankley NP; Rabinowitz MH
    Bioorg Med Chem; 2008 Apr; 16(7):3917-25. PubMed ID: 18289861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists.
    Robarge MJ; Bom DC; Tumey LN; Varga N; Gleason E; Silver D; Song J; Murphy SM; Ekema G; Doucette C; Hanniford D; Palmer M; Pawlowski G; Danzig J; Loftus M; Hunady K; Sherf BA; Mays RW; Stricker-Krongrad A; Brunden KR; Harrington JJ; Bennani YL
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1749-53. PubMed ID: 15745833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance.
    Levy C; Minnis D; Derrick JP
    Biochem J; 2008 Jun; 412(2):379-88. PubMed ID: 18321242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation.
    Kobayashi-Sakamoto M; Isogai E; Hirose K; Chiba I
    Microvasc Res; 2008 Nov; 76(3):139-44. PubMed ID: 18656492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ecdysteroid ligand-receptor selectivity--exploring trends to design orthogonal gene switches.
    Lapenna S; Friz J; Barlow A; Palli SR; Dinan L; Hormann RE
    FEBS J; 2008 Dec; 275(23):5785-809. PubMed ID: 19021756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5.
    Hattori K; Toda S; Imanishi M; Itou S; Nakajima Y; Washizuka K; Araki T; Hamashima H; Tomishima Y; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    J Med Chem; 2009 May; 52(9):3063-72. PubMed ID: 19366244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biphenylsulfonamide endothelin receptor antagonists. Part 3: structure-activity relationship of 4'-heterocyclic biphenylsulfonamides.
    Murugesan N; Gu Z; Stein PD; Spergel S; Bisaha S; Liu EC; Zhang R; Webb ML; Moreland S; Barrish JC
    Bioorg Med Chem Lett; 2002 Feb; 12(4):517-20. PubMed ID: 11844662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a sulfonamide series of CCR2 antagonists.
    Peace S; Philp J; Brooks C; Piercy V; Moores K; Smethurst C; Watson S; Gaines S; Zippoli M; Mookherjee C; Ife R
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3961-4. PubMed ID: 20627722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
    Martínez L; Polikarpov I; Skaf MS
    J Phys Chem B; 2008 Aug; 112(34):10741-51. PubMed ID: 18681473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.
    Bell MG; Gernert DL; Grese TA; Belvo MD; Borromeo PS; Kelley SA; Kennedy JH; Kolis SP; Lander PA; Richey R; Sharp VS; Stephenson GA; Williams JD; Yu H; Zimmerman KM; Steinberg MI; Jadhav PK
    J Med Chem; 2007 Dec; 50(26):6443-5. PubMed ID: 18038968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety.
    Imanishi M; Nakajima Y; Tomishima Y; Hamashima H; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Aug; 51(15):4804-22. PubMed ID: 18651730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators.
    Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Paradiso A
    Bioorg Med Chem; 2008 Apr; 16(7):3732-43. PubMed ID: 18276145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.